Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Severe Hemophilia A Study Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Severe Hemophilia A Study conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Severe Hemophilia A Study Clinical research trials and Severe Hemophilia A Study healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Severe Hemophilia A Study. Severe Hemophilia A Study Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Severe Hemophilia A Study clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Severe Hemophilia A Study condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Severe Hemophilia A Study

Severe Hemophilia A Study



Severe Hemophilia A Study

For Condition: Hemophilia A
Status: Recruiting
Sponsor(s): Wyeth-Ayerst Research ,
Synopsis: To characterize the safety and efficacy of ReFacto AF in treating acute bleeding episodes during prophylaxis treatment, including neoantigenicity.
Details:
Eligibility:
Study Type:
  Interventional, Treatment
Minimum Age/Maximum Age: 12 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Severe hemophilia A (FVIII:C less than or equal to 2% at local laboratory) - Previously treated patients with greater than or equal to 250 exposure days to any Factor VIII product - Age greater than or equal to 12 years - History of prophylaxis dosing at least twice per week on any Factor VIII product for at least 3 consecutive months within the 2 years prior to study enrollment unless the patient completed the previous pharmacokinetic study - Adequate laboratory results Exclusion Criteria: - Presence of any bleeding disorder in addition to hemophilia A - Concomitant therapy with immunosuppressive drugs - Current or historical Factor VIII inhibitor - Treatment with any investigational drug or device within the past 30 days
Total Enrollment: 

Location and Contact Information:

GOSH - Haemophilia Comprehensive Centre *Recruiting*
London,  ,  WC1 3JH
United Kingdom
Recruiting Ian  Hann +44 (0)20 7405 9200

Medizinische Hochschule Hannover *Recruiting*
Hannover,  ,  30625
Germany
Recruiting Mario  Depka +49 (0) 511 532-X

The Emory Clinic *Recruiting*
Atlanta,  Georgia,  30322-1100
United States
Recruiting Thomas  Abshire 404-778-5494

Children's Hospital of Michigan *Recruiting*
Detroit,  Michigan,  48201
United States
Recruiting Jeanne  Lusher 313-745-5515

Georgetown University Medical Center *Recruiting*
Washington D.C.,  District of Columbia,  20007-2197
United States
Recruiting Craig  Kessler 202-687-2223

University Hospital of Wales - Authur Bloom Haemophilia Centre *Recruiting*
Cardiff,  ,  CF4 4XN
United Kingdom
Recruiting Peter  Collins +44 (0) 29 2074 7747

University of Iowa Hospital and Clinic *Recruiting*
Iowa City,  Iowa,  52242
United States
Recruiting Jorge  DiPaola 319-356-2890

Newark Beth Israel Medical Center *Recruiting*
Newark,  New Jersey,  7112
United States
Recruiting Alice  Cohen 973-926-7230

University of Michigan Medical Center - Hemophilia  Treatment  Center *Recruiting*
Ann Arbor,  Michigan,  48109-0238
United States
Recruiting Steven  Pipe 734-936-6393

Hopital Edouard Herriot *Recruiting*
Lyon Cedex 03,  ,  69437
France
Recruiting Claude  Negrier 33472117338

University of Medicine and Dentistry of New Jersey *Recruiting*
New Brunswick,  New Jersey,  08903
United States
Recruiting Claire  Phillip 732-235-7682

Phoenix Children's Hospital - Hemophilia Treatment Center *Recruiting*
Phoenix,  Arizona,  85016
United States
Recruiting Michael  Recht 602-546-0920

Children's Hospital Medical Center *Recruiting*
Cincinnati,  Ohio,  45229
United States
Recruiting Ralph  Gruppo 513-636-4269

Manchester Royal Infirmary - Haemophilia Comprehensive Care Centre *Recruiting*
Manchester,  ,  M13 9WL
United Kingdom
Recruiting Charles  Hay +44 (0) 161 276 4812

The New York Hospital-Cornell Medical Center *Recruiting*
New York City,  New York,  10021
United States
Recruiting Donna  DiMichele 212-746-3400

Indiana Hemophilia and Thrombosis Center *Recruiting*
Indianapolis,  Indiana,  46260
United States
Recruiting Amy  Shapiro 317-338-7200

University of New Mexico - Ted R. Montoya Hemophilia Center *Recruiting*
Albuquerque,  New Mexico,  97131
United States
Recruiting Prasad  Mathew 505-272-4461

UNC School of Medicine *Recruiting*
Chapel Hill,  North Carolina,  27599-7035
United States
Recruiting Gilbert  White 919-996-3311

University of Texas Houston Medical School *Recruiting*
Houston,  Texas,  77030
United States
Recruiting W.  Hoots 713-500-8360


Additional Information:
Study ID Numbers:
  3082B1-306-GL; 
Study Start Date: 
Record last reviewed: October 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00037544

Other Hemophilia A Studies:
1. Delta Hepatitis and Liver Disease in Hemophiliacs

2. Prospective Study of HIV Infection in Hemophiliacs

3. Epidemiology and Immunology of Hemophilia A Inhibitors

4. Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males with Hemophilia

5. Hemophilia A Study

Related Studies:

Other Hemophilia A Clinical Trials
Other District of Columbia Clinical Trials
Other Washington D.C. Clinical Trials

Severe Hemophilia A Study

Modify your Search

  Other Hemophilia A Clinical Trials
  Other District of Columbia Clinical Trials
  Other Washington D.C. Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103